using imidazolines as an organocatalyst, i.e., the newly
designed C3-symmetric chiral trisimidazoline 1a (Figure 1ii),
with the concept of constructing C3-symmetric molecules
with three C2-symmetric chiral components, as a Brønsted
base catalyst8 for the enantioselective conjugate addition of
R-substituted ꢀ-ketoesters to nitroolefins.
Table 1. Evaluation of the Imidazolines 1a-ca
Imidazolines derived from C2-symmetric diamines, such as
chiral 1,2-diphenyl ethylenediamine, have a symmetrical struc-
ture. To utilize the symmetric nature of imidazolines, we
designed the C3-symmetric trisimidazoline 1a (Figure 1ii): three-
imidazoline rings were substituted on the 1-, 3-, and 5-positions
of the benzene ring. Since the interesting molecular recognition
of trisimidazoline derived from ethylenediamine was reported
to form 1:3 complexes with carboxylic acids or tetrazoles,9 we
expected that 1a would have good interactions between the
reaction substrates and provide a unique chiral environment.
We chose the ꢀ-ketoester as a substrate assuming that the
enolate of the ꢀ-ketoester and trisimidazoline 1a could form a
complex through hydrogen-bonding interactions. The conjugate
addition of R-substituted ꢀ-ketoesters to nitroolefins was initially
studied, because this reaction is very attractive from the point of
constructing quaternary and tertiary stereocenters in one step.10,11
The C3-symmetric trisimidazoline 1a was readily prepared
by a one-pot condensation-oxidation procedure developed
by us12 from trialdehyde 2 and chiral diamine 3 with NBS
(Scheme 1). In the same way, bisimidazoline 1b and
monoimidazoline 1c were also prepared for comparison.
entry
cat.
loading (mol %) yield (%) (dr) ee (%)b
1
2
3
1a (tris)
1b (bis)
1c (mono)
1a (tris)
1b (bis)
1a (tris)
5
5
5
94 (18:1)
91 (18:1)
29 (5:1)
89
61
1
4
2.5
7.5
5
97 (18:1)
90 (16:1)
95 (20:1)
90
67
95
5
6c
a Unless otherwise noted, the reaction was carried out with 4 (0.14 mmol)
and 5 (0.21 mmol) with 1 in toluene (0.47 mL) at rt. b Ee of major
diastereomer is shown. c -10 °C.
delight, the C3-symmetric trisimidazoline 1a had a good
enantioselectivity (entry 1, 89% ee). A moderate selectivity
was obtained with bisimidazoline 1b (entry 2, 61% ee), while
monoimidazoline 1c produced an almost racemic product
(entry 3, 1% ee). The reduction of the loading of 1a and the
increase of 1b did not have significant influence on the
selectivity: 2.5 mol % of 1a afforded 6a in 90% ee (entry 4)
and 7.5 mol % of 1b afforded 6a in 67% ee (entry 5). These
results indicated that at least two imidazolines on the benzene
ring were essential for this reaction and the structure of
trisimidazoline 1a was much more effective than that of
bisimidazoline 1b. Encouraged by these results, we screened
several solvents to optimize the conditions using 1a. Details
are shown in the Supporting Information, and less polar solvents
tended to produce a good enantioselectivity but a protic solvent,
such as MeOH, resulted in a poor selectivity (4% ee). After
the optimization, lowering the reaction temperature to -10 °C
led to a further improvement of the enantioselectivity (entry 6,
95% ee) with high diastereoselectivity.
Scheme 1. Preparation of Trisimidazoline 1a (left) and
Structures of Bisimidazoline 1b and Monoimidazoline 1c (right)
With the optimized reaction conditions in hand, the
generality of the reactions using the several nitroolefins and
ꢀ-ketoesters was investigated (Table 2). The reaction of
ꢀ-ketoester 4a with different substituted aromatic nitroolefins,
such as electron-rich, electron-poor, bulky, and heteroaro-
matic ones, afforded the corresponding adducts in good yields
with high diastereo- and enantioselectivities (entries 1-7).
The reaction of methyl 2-oxocyclopentanecarboxylate (4a)
and ꢀ-nitrostyrene (5a) was examined to evaluate the
imidazoline catalysts 1a-c (5 mol %) (Table 1). To our
(5) For reviews, see: (a) Moberg, C. Angew. Chem., Int. Ed. 1998, 37,
248. (b) Gibson, S. E.; Castaldi, M. P. Angew. Chem., Int. Ed. 2006, 45,
4718. (c) Moberg, C. Angew. Chem., Int. Ed. 2006, 45, 4721. (d) Gibson,
S. E.; Castaldi, M. P. Chem. Commun. 2006, 3045.
(10) For selected reviews on asymmetric 1,4-addition, see: (a) Tsogoeva,
S. B. Eur. J. Org. Chem. 2007, 1701. (b) Christoffers, J.; Koripelly, G.;
Rosiak, A.; Ro¨ssle, M. Synthesis 2007, 1279.
(11) For selected recent examples with organocatalysts, see: (a) Li, H.;
Wang, Y.; Tang, L.; Wu, F.; Liu, X.; Guo, C.; Foxman, B. M.; Deng, L.
Angew. Chem., Int. Ed. 2005, 44, 105. (b) Okino, T.; Hoashi, Y.; Furukawa,
T.; Xu, X.; Takemoto, Y. J. Am. Chem. Soc. 2005, 127, 119. (c) Terada,
M.; Ube, H.; Yaguchi, Y. J. Am. Chem. Soc. 2006, 128, 1454. (d) Zhang,
Z.-H.; Dong, X.-Q.; Chen, D.; Wang, C.-J. Chem.sEur. J. 2008, 14, 8780.
(e) Yu, Z.; Liu, X.; Zhou, L.; Lin, L.; Feng, X. Angew. Chem., Int. Ed.
2009, 48, 5195. (f) Luo, J.; Xu, L.-W.; Hay, R. A. S.; Lu, Y. Org. Lett.
2009, 11, 437. (g) Jiang, X.; Zhang, Y.; Liu, X.; Zhang, G.; Lai, L.; Wu,
L.; Zhang, J.; Wang, R. J. Org. Chem. 2009, 74, 5562.
(6) Interesting molecular recognitions and chiral ligands with C3-
symmetric trisoxazolines were reported. For examples, see: (a) Kim, S.-
G.; Kim, K.-H.; Jung, J.; Shin, S. K.; Ahn, K. H. J. Am. Chem. Soc. 2002,
124, 591. (b) Ahn, K. H.; Ku, H.-Y.; Kim, Y.; Kim, S.-G.; Kim, Y. K.;
Son, H. S.; Ku, J. K. Org. Lett. 2003, 5, 1419. (c) Gade, L. H.; Bellemin-
Laponnaz, S. Chem.sEur. J. 2008, 14, 4142.
(7) Han, J.; Wu, H.; Teng, M.; Li, Z.; Wang, Y.; Wang, L.; Pan, Y.
Synlett 2009, 933.
(8) Palomo, C.; Oiarbide, M.; Lo´pez, R. Chem. Soc. ReV. 2009, 38, 632.
(9) (a) Kraft, A.; Fro¨hlich, R. Chem. Commun. 1998, 1085. (b) Kraft,
A.; Osterod, F.; Fro¨hlich, R. J. Org. Chem. 1999, 64, 6425. For another
interesting propery of trisimidazolines, see: (c) Nam, S. R.; Kim, H.-J.;
Sakamoto, S.; Yamaguchi, K.; Hong, J.-I. Tetrahedron Lett. 2004, 45, 1339–
1342. (d) Yan, L.; Wang, Z.; Chen, M.-T.; Wu, N.; Lan, J.; Gao, X.; You,
J.; Gau, H.-M.; Chen, C.-T. Chem.sEur. J. 2008, 14, 11601–11609.
(12) (a) Fujioka, H.; Murai, K.; Ohba, Y.; Hiramatsu, A.; Kita, Y.
Tetrahedron Lett. 2005, 46, 2197. (b) Fujioka, H.; Murai, K.; Kubo, O.;
Ohba, Y.; Kita, Y. Tetrahedron 2007, 63, 638. For our related works, see:
(c) Murai, K.; Morishita, M.; Nakatani, R.; Kubo, O.; Fujioka, H.; Kita, Y.
J. Org. Chem. 2007, 72, 8947. (d) Murai, K.; Morishita, M.; Nakatani, R.;
Fujioka, H.; Kita, Y. Chem. Commun. 2008, 4498.
Org. Lett., Vol. 12, No. 5, 2010
965